o-naphthalenedicarboxaldehyde derivative of 7′-aminonaltrindole as a selective δ-opioid receptor affinity label

Sarika Prabhu Haris, Yan Zhang, Bertrand Le Bourdonnec, Christopher R. McCurdy, Philip S Portoghese

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Incorporation of a naphthalene-dialdehyde moiety into the δ antagonist, 6′-aminonaltrindole afforded a potent, selective, irreversible δ-agonist 1. However, flow cytometry studies revealed no time-dependent specific fluorescence, suggesting that both Lys214 and Cys216 at the recognition site are not involved in covalent binding. Molecular simulation studies suggest that compound 1 may form a Schiff base with the ε-amino group of Lys214, which could explain its irreversibility and transformation into a δ-agonist through a conformational change of TM5.

Original languageEnglish (US)
Pages (from-to)3392-3396
Number of pages5
JournalJournal of Medicinal Chemistry
Volume50
Issue number14
DOIs
StatePublished - Jul 12 2007

Fingerprint

Affinity Labels
Schiff Bases
Opioid Receptors
Flow Cytometry
Fluorescence
naphthalene

Cite this

o-naphthalenedicarboxaldehyde derivative of 7′-aminonaltrindole as a selective δ-opioid receptor affinity label. / Haris, Sarika Prabhu; Zhang, Yan; Le Bourdonnec, Bertrand; McCurdy, Christopher R.; Portoghese, Philip S.

In: Journal of Medicinal Chemistry, Vol. 50, No. 14, 12.07.2007, p. 3392-3396.

Research output: Contribution to journalArticle

Haris, Sarika Prabhu ; Zhang, Yan ; Le Bourdonnec, Bertrand ; McCurdy, Christopher R. ; Portoghese, Philip S. / o-naphthalenedicarboxaldehyde derivative of 7′-aminonaltrindole as a selective δ-opioid receptor affinity label. In: Journal of Medicinal Chemistry. 2007 ; Vol. 50, No. 14. pp. 3392-3396.
@article{2d63e67aa5e4404faef481721bdf0c89,
title = "o-naphthalenedicarboxaldehyde derivative of 7′-aminonaltrindole as a selective δ-opioid receptor affinity label",
abstract = "Incorporation of a naphthalene-dialdehyde moiety into the δ antagonist, 6′-aminonaltrindole afforded a potent, selective, irreversible δ-agonist 1. However, flow cytometry studies revealed no time-dependent specific fluorescence, suggesting that both Lys214 and Cys216 at the recognition site are not involved in covalent binding. Molecular simulation studies suggest that compound 1 may form a Schiff base with the ε-amino group of Lys214, which could explain its irreversibility and transformation into a δ-agonist through a conformational change of TM5.",
author = "Haris, {Sarika Prabhu} and Yan Zhang and {Le Bourdonnec}, Bertrand and McCurdy, {Christopher R.} and Portoghese, {Philip S}",
year = "2007",
month = "7",
day = "12",
doi = "10.1021/jm061194h",
language = "English (US)",
volume = "50",
pages = "3392--3396",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "14",

}

TY - JOUR

T1 - o-naphthalenedicarboxaldehyde derivative of 7′-aminonaltrindole as a selective δ-opioid receptor affinity label

AU - Haris, Sarika Prabhu

AU - Zhang, Yan

AU - Le Bourdonnec, Bertrand

AU - McCurdy, Christopher R.

AU - Portoghese, Philip S

PY - 2007/7/12

Y1 - 2007/7/12

N2 - Incorporation of a naphthalene-dialdehyde moiety into the δ antagonist, 6′-aminonaltrindole afforded a potent, selective, irreversible δ-agonist 1. However, flow cytometry studies revealed no time-dependent specific fluorescence, suggesting that both Lys214 and Cys216 at the recognition site are not involved in covalent binding. Molecular simulation studies suggest that compound 1 may form a Schiff base with the ε-amino group of Lys214, which could explain its irreversibility and transformation into a δ-agonist through a conformational change of TM5.

AB - Incorporation of a naphthalene-dialdehyde moiety into the δ antagonist, 6′-aminonaltrindole afforded a potent, selective, irreversible δ-agonist 1. However, flow cytometry studies revealed no time-dependent specific fluorescence, suggesting that both Lys214 and Cys216 at the recognition site are not involved in covalent binding. Molecular simulation studies suggest that compound 1 may form a Schiff base with the ε-amino group of Lys214, which could explain its irreversibility and transformation into a δ-agonist through a conformational change of TM5.

UR - http://www.scopus.com/inward/record.url?scp=34447540010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447540010&partnerID=8YFLogxK

U2 - 10.1021/jm061194h

DO - 10.1021/jm061194h

M3 - Article

VL - 50

SP - 3392

EP - 3396

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 14

ER -